<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02573818</url>
  </required_header>
  <id_info>
    <org_study_id>SED-14-001</org_study_id>
    <nct_id>NCT02573818</nct_id>
  </id_info>
  <brief_title>Sedasys Post Approval Study Users Response to System Alarms</brief_title>
  <official_title>Open-Label Post Approval Study of the SEDASYS System User Response to System Alarms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the users' responses to the SEDASYS® System alarms
      during esophagogastroduodenoscopy (EGD) or colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    franchise closed; no safety concerns
  </why_stopped>
  <start_date type="Actual">September 1, 2015</start_date>
  <completion_date type="Actual">June 15, 2016</completion_date>
  <primary_completion_date type="Actual">June 15, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of documented responses/actions taken in response to SEDASYS System alarms (oxygen desaturation, apnea, hypotension, and bradycardia alarms)</measure>
    <time_frame>&lt;24 hours, i.e., for duration of study procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fraction of users responses/actions to oxygen desaturation, apnea, hypotension, and/or bradycardia alarms deemed sufficient by Endpoint Adjudication Committee (EAC)</measure>
    <time_frame>assessment of sufficient alarms will be reviewed by EAC after 100, 400, and 866 subjects completed the study</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Conscious Sedation</condition>
  <arm_group>
    <arm_group_label>SEDASYS System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SEDASYS System</intervention_name>
    <description>propofol sedation with the SEDASYS System</description>
    <arm_group_label>SEDASYS System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female subjects 18 years or older scheduled for colonoscopy or EGD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) I and II

          -  male and female

          -  Scheduled for routine colonoscopy or EGD

          -  ≥18 years of age

          -  Able to read, speak, and understand English

        Exclusion Criteria:

          -  Physical or psychological condition which would impair trial participation, at the
             discretion of the PI

          -  BMI ≥ 35

          -  Pregnancy or lactation

          -  Known or suspected hypersensitivity to propofol or fentanyl

          -  Use of a fentanyl patch

          -  Allergies to eggs, egg products soybeans or soy products

          -  Diagnosis of sleep apnea

          -  Gastroparesis

          -  Full stomach at the time of procedure

          -  Participation in any other investigational device or drug study within 30 days of
             enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James F Martin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon Endo-Surgery, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ProMedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2015</study_first_posted>
  <last_update_submitted>March 22, 2017</last_update_submitted>
  <last_update_submitted_qc>March 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sedation for EGD and colonoscopy procedures</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

